Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TVP23B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GATAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BBS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL6IP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOB1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728485 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NUDT12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KBTBD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP160 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1CB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUMO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BNIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on